Genome-wide profiling identified a set of miRNAs that are differentially expressed in glioblastoma stem cells and normal neural stem cells

PLoS ONE

Volumn 7, Issue 4, 2012, Pages

  Lang, Ming Fei ^a   Yang, Su ^a   Zhao, Chunnian ^a   Sun, Guoqiang ^a   Murai, Kiyohito ^a   Wu, Xiwei ^a   Wang, Jinhui ^a   Gao, Hanlin ^a   Brown, Christine E ^a   Liu, Xiaoxuan ^b   Zhou, Jiehua ^a   Peng, Ling ^b   Rossi, John J ^a   Shi, Yanhong ^a  

^a CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

^b AIX MARSEILLE UNIVERSITÉ   (France)

Author keywords

[No Author keywords available]

Indexed keywords

MICRORNA; MICRORNA 10A; MICRORNA 10B; MICRORNA 124; UNCLASSIFIED DRUG;

ANIMAL TISSUE; ARTICLE; CANCER STEM CELL; CONTROLLED STUDY; CSMD1 GENE; DOWN REGULATION; GENE EXPRESSION PROFILING; GENE SEQUENCE; GENE TARGETING; GENOME ANALYSIS; GLIOBLASTOMA; HUMAN; HUMAN CELL; HUMAN GENOME; MICROARRAY ANALYSIS; NEURAL STEM CELL; NONHUMAN; ONCOGENE; ONCOGENE NRAS; ONCOGENE PIM3; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TISSUE SECTION; TUMOR SUPPRESSOR GENE; UPREGULATION; DNA MICROARRAY; GENETICS; GENOMICS; HIGH THROUGHPUT SEQUENCING; METABOLISM; PATHOLOGY; REPRODUCIBILITY; SEQUENCE ANALYSIS; TUMOR CELL LINE;

CELL LINE, TUMOR; DOWN-REGULATION; GENE EXPRESSION PROFILING; GENES, TUMOR SUPPRESSOR; GENOMICS; GLIOBLASTOMA; HIGH-THROUGHPUT NUCLEOTIDE SEQUENCING; HUMANS; MICRORNAS; NEOPLASTIC STEM CELLS; NEURAL STEM CELLS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; REPRODUCIBILITY OF RESULTS; SEQUENCE ANALYSIS, RNA; UP-REGULATION;

EID: 84860448293     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0036248     Document Type: Article

References (46)

1. Louis DN, Ohgaki H, Wiestler OD, Cavenee WK, Burger PC, et al. (2007) The 2007 WHO classification of tumours of the central nervous system. Acta neuropathologica 114: 97-109.
2. Singh SK, Hawkins C, Clarke ID, Squire JA, Bayani J, et al. (2004) Identification of human brain tumour initiating cells. Nature 432: 396-401.
3. Bao S, Wu Q, McLendon RE, Hao Y, Shi Q, et al. (2006) Glioma stem cells promote radioresistance by preferential activation of the DNA damage response. Nature 444: 756-760.
4. Godlewski J, Newton HB, Chiocca EA, Lawler SE, (2010) MicroRNAs and glioblastoma; the stem cell connection. Cell death and differentiation 17: 221-228.
5. Ambros V, (2004) The functions of animal microRNAs. Nature 431: 350-355.
6. Bartel DP, (2004) MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116: 281-297.
7. Shi Y, Zhao X, Hsieh J, Wichterle H, Impey S, et al. (2010) MicroRNA regulation of neural stem cells and neurogenesis. J Neuroscience 30: 14931-14936.
8. Esquela-Kerscher A, Slack FJ, (2006) Oncomirs- microRNAs with a role in cancer. Nat Rev Cancer 6: 259-269.
9. Asadi-Moghaddam K, Chiocca EA, Lawler SE, (2010) Potential role of miRNAs and their inhibitors in glioma treatment. Expert review of anticancer therapy 10: 1753-1762.
10. Cheng L, Bao S, Rich JN, (2010) Potential therapeutic implications of cancer stem cells in glioblastoma. Biochemical pharmacology 80: 654-665.
11. Conti A, Aguennouz M, La Torre D, Tomasello C, Cardali S, et al. (2009) miR-21 and 221 upregulation and miR-181b downregulation in human grade II-IV astrocytic tumors. Journal of neuro-oncology 93: 325-332.
12. Huse JT, Brennan C, Hambardzumyan D, Wee B, Pena J, et al. (2009) The PTEN-regulating microRNA miR-26a is amplified in high-grade glioma and facilitates gliomagenesis in vivo. Genes & development 23: 1327-1337.
13. Kim H, Huang W, Jiang X, Pennicooke B, Park PJ, et al. (2010) Integrative genome analysis reveals an oncomir/oncogene cluster regulating glioblastoma survivorship. Proceedings of the National Academy of Sciences of the United States of America 107: 2183-2188.
14. Silber J, Lim DA, Petritsch C, Persson AI, Maunakea AK, et al. (2008) miR-124 and miR-137 inhibit proliferation of glioblastoma multiforme cells and induce differentiation of brain tumor stem cells. BMC medicine 6: 14.
15. Gal H, Pandi G, Kanner AA, Ram Z, Lithwick-Yanai G, et al. (2008) MIR-451 and Imatinib mesylate inhibit tumor growth of Glioblastoma stem cells. Biochemical and biophysical research communications 376: 86-90.
16. Lewis BP, Shih IH, Jones-Rhoades MW, Bartel DP, Burge CB, (2003) Prediction of mammalian microRNA targets. Cell 115: 787-798.
17. Kamal M, Shaaban AM, Zhang L, Walker C, Gray S, et al. (2010) Loss of CSMD1 expression is associated with high tumour grade and poor survival in invasive ductal breast carcinoma. Breast cancer research and treatment 121: 555-563.
18. Ma L, Teruya-Feldstein J, Weinberg RA, (2007) Tumour invasion and metastasis initiated by microRNA-10b in breast cancer. Nature 449: 682-688.
19. Kiessling MK, Oberholzer PA, Mondal C, Karpova MB, Zipser MC, et al. (2011) High-throughput mutation profiling of CTCL samples reveals KRAS and NRAS mutations sensitizing tumors toward inhibition of the RAS/RAF/MEK signaling cascade. Blood 117: 2433-2440.
20. Kan Z, Jaiswal BS, Stinson J, Janakiraman V, Bhatt D, et al. (2010) Diverse somatic mutation patterns and pathway alterations in human cancers. Nature 466: 869-873.
21. Zhou J, Wu J, Hafdi N, Behr J-P, Erbacher P, et al. (2006) PAMAM dendrimers for efficient siRNA delivery and potent gene silencing. Chem Commun 22: 2362-2364.
22. Zhou J, Neff CP, Liu X, Zhang J, Li H, et al. (2011) Systemic administration of combinatorial dsiRNAs via nanoparticles efficiently suppresses HIV-1 infection in humanized mice. Mol Ther 19: 2228-2238.
23. Wu Y, Wang YY, Nakamoto Y, Li YY, Baba T, et al. (2010) Accelerated hepatocellular carcinoma development in mice expressing the Pim-3 transgene selectively in the liver. Oncogene 29: 2228-2237.
24. Brault L, Gasser C, Bracher F, Huber K, Knapp S, et al. (2010) PIM serine/threonine kinases in the pathogenesis and therapy of hematologic malignancies and solid cancers. Haematologica 95: 1004-1015.
25. Junttila MR, Evan GI, (2009) p53-a Jack of all trades but master of none. Nat Rev Cancer 9: 821-829.
26. Clayton PE, Banerjee I, Murray PG, Renehan AG, (2011) Growth hormone, the insulin-like growth factor axis, insulin and cancer risk. Nat Rev Endocrinol 7: 11-24.
27. Ciafre SA, Galardi S, Mangiola A, Ferracin M, Liu CG, et al. (2005) Extensive modulation of a set of microRNAs in primary glioblastoma. Biochemical and biophysical research communications 334: 1351-1358.
28. Godlewski J, Nowicki MO, Bronisz A, Williams S, Otsuki A, et al. (2008) Targeting of the Bmi-1 oncogene/stem cell renewal factor by microRNA-128 inhibits glioma proliferation and self-renewal. Cancer research 68: 9125-9130.
29. Xia H, Cheung WK, Ng SS, Jiang X, Jiang S, et al. (2012) Loss of brain-enriched miR-124 enhances the stem-like traits and invasiveness of glioma cells. The Journal of biological chemistry.
30. Skalsky RL, Cullen BR, (2011) Reduced expression of brain-enriched microRNAs in glioblastomas permits targeted regulation of a cell death gene. PloS one 6: e24248.
31. Fowler A, Thomson D, Giles K, Maleki S, Mreich E, et al. (2011) miR-124a is frequently down-regulated in glioblastoma and is involved in migration and invasion. Eur J Cancer 47: 953-963.
32. Gabriely G, Yi M, Narayan RS, Niers JM, Wurdinger T, et al. (2011) Human glioma growth is controlled by microRNA-10b. Cancer research 71: 3563-3572.
33. Calin GA, Liu CG, Sevignani C, Ferracin M, Felli N, et al. (2004) MicroRNA profiling reveals distinct signatures in B cell chronic lymphocytic leukemias. Proceedings of the National Academy of Sciences of the United States of America 101: 11755-11760.
34. Bloomston M, Frankel WL, Petrocca F, Volinia S, Alder H, et al. (2007) MicroRNA expression patterns to differentiate pancreatic adenocarcinoma from normal pancreas and chronic pancreatitis. Jama 297: 1901-1908.
35. Li KK, Pang JC, Ching AK, Wong CK, Kong X, et al. (2009) miR-124 is frequently down-regulated in medulloblastoma and is a negative regulator of SLC16A1. Human pathology 40: 1234-1243.
36. Furuta M, Kozaki KI, Tanaka S, Arii S, Imoto I, et al. (2010) miR-124 and miR-203 are epigenetically silenced tumor-suppressive microRNAs in hepatocellular carcinoma. Carcinogenesis 31: 766-776.
37. Hunt S, Jones AV, Hinsley EE, Whawell SA, Lambert DW, (2011) MicroRNA-124 suppresses oral squamous cell carcinoma motility by targeting ITGB1. FEBS letters 585: 187-192.
38. Ming GL, Song H, (2011) Adult neurogenesis in the mammalian brain: significant answers and significant questions. Neuron 70: 687-702.
39. Verissimo CS, Molenaar JJ, Fitzsimons CP, Vreugdenhil E, (2011) Neuroblastoma therapy: what is in the pipeline? Endocrine-related cancer 18: R213-231.
40. Rao SA, Santosh V, Somasundaram K, (2010) Genome-wide expression profiling identifies deregulated miRNAs in malignant astrocytoma. Mod Pathol 23: 1404-1417.
41. Roth P, Wischhusen J, Happold C, Chandran PA, Hofer S, et al. (2011) A specific miRNA signature in the peripheral blood of glioblastoma patients. Journal of neurochemistry 118: 449-457.
42. Brown CE, Starr R, Martinez C, Aguilar B, D'Apuzzo M, et al. (2009) Recognition and killing of brain tumor stem-like initiating cells by CD8+ cytolytic T cells. Cancer research 69: 8886-8893.
43. Zhao C, Sun G, Li S, Shi Y, (2009) A feedback regulatory loop involving microRNA-9 and nuclear receptor TLX in neural stem cell fate determination. Nature Structural & Molecular Biology 16: 365-371.
44. Zhao C, Sun G, Li S, Lang M-F, Yang S, et al. (2010) MicroRNA let-7b regulates neural stem cell proliferation and differentiation by targeting nuclear receptor TLX signaling. Proceedings of the National Academy of Sciences of the United States of America 107: 1876-1881.
45. Sun G, Ye P, Murai K, Lang M-F, Li S, et al. (2011) miR-137 forms a regulatory loop with nuclear receptor TLX and LSD1 in neural stem cells. Nature Communications 2: 529 DOI:10.1038/ncomms1532.
46. Sun G, Yu R, Evans RM, Shi Y, (2007) Orphan nuclear receptor TLX recruits histone deacetylases to repress transcription and regulate neural stem cell proliferation. Proceedings of the National Academy of Sciences of the United States of America 104: 15282-15287.